# FDA Inspection 769326 - Catalent Pharma Solutions, LLC - February 17, 2012

Source: https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/bc2fc2cb-10db-4dbf-83d9-7b549f0d1da8
Source feed: FDA_Inspections

> FDA Inspection 769326 for Catalent Pharma Solutions, LLC on February 17, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 769326
- Company Name: Catalent Pharma Solutions, LLC
- Inspection Date: 2012-02-17
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1285382 - 2025-11-21](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/ff8fc52d-bf9c-42ed-b3c5-9a5ec1212111)
- [FDA Inspection 1285382 - 2025-11-21](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/fcf91a3b-6f3b-43fd-8d95-73fc26c931e6)
- [FDA Inspection 1199635 - 2023-02-01](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/29026bc3-0257-48ed-98f2-f7393b135ed7)
- [FDA Inspection 1063006 - 2018-07-13](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/730b5392-7dac-4e45-b51a-02c7c84f6cdd)
- [FDA Inspection 1039238 - 2018-01-19](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/84731a92-74a9-499d-98d1-6a1418cb216b)

Company: https://www.keypedia.com/companies/catalent-pharma-solutions-llc/311196d9-b80d-4a77-a294-dab360325781

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c